A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

2016

A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1)

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

5

Citations